Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Neumann

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|September 24, 2004
Identification of an HLA-DR-restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM-MEL-40/SSX2Frank Neumann, Claudia Wagner, Stefan Stevanovic, et al.
Annals of Hematology|April 28, 2006
Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin's lymphomaFrank Neumann, Stefani Harmsen, Simona Martin, et al.
Cancer Treatment and Research Communications|July 1, 2021
Comparison of incidence/occurrence of cardiovascular events between ponatinib vs bosutinib among patients with at least one prior line of tyrosine kinase inhibitors in chronic myeloid leukemia in a community setting in the United StatesMoshe Levy, Lin Xie, Yuexi Wang, et al.
Chemosphere|July 19, 2011
Inactivation of LPS and RNase A on photocatalytically active surfacesJochen Kurz, Florian Eberle, Tobias Graumann, et al.
Annals of Hematology|February 25, 2009
Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigensCarsten Zwick, Klaus-Dieter Preuss, Boris Kubuschok, et al.
Nutrients|August 26, 2023
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal AntibodiesKonstantinos Christofyllakis, Frank Neumann, Moritz Bewarder, et al.
International Journal of Cancer|August 9, 2008
Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cellsGerhard Held, Frank Neumann, Christine Sturm, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2013
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumorsFrank Neumann, Dominic Kaddu-Mulindwa, Thomas Widmann, et al.
Annals of Hematology|January 10, 2025
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experienceFelicitas Schulz, Claudia Roggenbuck, Andrea Kündgen, et al.
Leukemia & Lymphoma|December 11, 2007
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myelomaRoland Fenk, Mark Michael, Fabian Zohren, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|September 24, 2004
Identification of an HLA-DR-restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM-MEL-40/SSX2Frank Neumann, Claudia Wagner, Stefan Stevanovic, et al.
Annals of Hematology|April 28, 2006
Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin's lymphomaFrank Neumann, Stefani Harmsen, Simona Martin, et al.
Cancer Treatment and Research Communications|July 1, 2021
Comparison of incidence/occurrence of cardiovascular events between ponatinib vs bosutinib among patients with at least one prior line of tyrosine kinase inhibitors in chronic myeloid leukemia in a community setting in the United StatesMoshe Levy, Lin Xie, Yuexi Wang, et al.
Chemosphere|July 19, 2011
Inactivation of LPS and RNase A on photocatalytically active surfacesJochen Kurz, Florian Eberle, Tobias Graumann, et al.
Annals of Hematology|February 25, 2009
Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigensCarsten Zwick, Klaus-Dieter Preuss, Boris Kubuschok, et al.
Nutrients|August 26, 2023
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal AntibodiesKonstantinos Christofyllakis, Frank Neumann, Moritz Bewarder, et al.
International Journal of Cancer|August 9, 2008
Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cellsGerhard Held, Frank Neumann, Christine Sturm, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2013
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumorsFrank Neumann, Dominic Kaddu-Mulindwa, Thomas Widmann, et al.
Annals of Hematology|January 10, 2025
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experienceFelicitas Schulz, Claudia Roggenbuck, Andrea Kündgen, et al.
Leukemia & Lymphoma|December 11, 2007
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myelomaRoland Fenk, Mark Michael, Fabian Zohren, et al.
Pageof 12